Listed by the USPTO as PRIEST, JESSICA MARIE
Tech Center 1600 • Art Units: 1618 1642 1643
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18472160 | METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 18404727 | ANTI-FIBROTIC TISSUE RESIDENT MEMORY T CELLS AND USES THEREOF | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18571614 | Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins | Non-Final OA | AMGEN INC. |
| 18580255 | METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1 ANTAGONIST, AN ILT4 ANTAGONIST, AND CHEMOTHERAPEUTIC AGENTS | Non-Final OA | Merck Sharp & Dohme LLC |
| 18711286 | METHOD FOR THE TREATMENT OF PROGRESSIVE CHRONIC INTERSTITIAL LUNG DISEASE | Non-Final OA | UCB Biopharma SRL |
| 18350637 | IGM-MULTIMERIZED SINGLE-DOMAIN ANTIBODIES THAT BIND ROR1 | Non-Final OA | Fred Hutchinson Cancer Center |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyJessica Marie Priest examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).